Biot, France

Guy Bouvier

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guy Bouvier: Innovator in Skin Tumor Treatment

Introduction

Guy Bouvier is a notable inventor based in Biot, France. He has made significant contributions to the field of dermatology, particularly in the prevention and treatment of skin tumors. With a total of two patents to his name, Bouvier's work is recognized for its innovative approaches to addressing skin health.

Latest Patents

Bouvier's latest patents focus on methods, compositions, and products for preventing skin tumor formation or inhibiting the development of existing skin tumors. One of his key inventions involves administering a composition containing an α adrenergic receptor agonist, such as brimonidine, to subjects. This method aims to provide effective treatment options for individuals at risk of skin tumors.

Career Highlights

Throughout his career, Guy Bouvier has been associated with Galderma Research & Development, where he has contributed to groundbreaking research in dermatological treatments. His expertise in the field has led to advancements that benefit patients and healthcare providers alike.

Collaborations

Bouvier has worked alongside notable colleagues, including Matthew James Leoni and Michael Graeber. Their collaborative efforts have further enhanced the research and development of innovative skin treatment solutions.

Conclusion

Guy Bouvier's contributions to the field of dermatology through his patents and research at Galderma Research & Development highlight his commitment to improving skin health. His innovative methods for preventing and treating skin tumors represent a significant advancement in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…